Tobacco: Clinical Trials

3 trials for Tobacco, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Active not recruiting 1, Not yet recruiting 1, Recruiting 1

Follow Tobacco: new trials by email Literature Review of Tobacco trials Research Report on Tobacco

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking
Daridorexant 50 mg, Placebo - Smoking, Nicotine
Phase 4Not yet recruitingLegacy Health System442026-02-102026-01-09
Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
Nicotine Replacement Therapy (Nicotine patch plus NRT gum or lozenge), Cytisine, Varenicline (Champix) - Tobacco
Phase 4RecruitingOttawa Heart Institute Research Corporation1502025-04-302026-03-05
Secondhand Smoke Respiratory Health Study
Albuterol, Placebo - Secondhand Smoke, Air Trapping
Phase 4Active not recruitingUniversity of California, San Francisco1072016-06-062026-06-04

Narrower conditions

Behavior, Addictive (1)  ·  Lung Diseases, Obstructive (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Smoking (1)  ·  Substance-Related Disorders (1)  ·  Tobacco Use Cessation (1)

Broader conditions

Behavior (2)  ·  Chemically-Induced Disorders (1)  ·  Compulsive Behavior (1)  ·  Dyssomnias (1)  ·  Health Behavior (1)  ·  Impulsive Behavior (1)  ·  Lung Diseases (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Sleep Disorders, Intrinsic (1)  ·  Sleep Wake Disorders (1)

Interventions

Albuterol (1)  ·  Nicotine Replacement Therapy (1)  ·  Procaterol (1)  ·  Tobacco Use Cessation Devices (1)  ·  Varenicline (1)  ·  cytisine (1)  ·  daridorexant (1)

Sponsors

Legacy Health System (1)  ·  Ottawa Heart Institute Research Corporation (1)  ·  University of California, San Francisco (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Mehrdad Arjomandi, MD (1)

Results publications

PMID 42492489